Company intelligence / Profile preview

UroMed Brachytherapy

Needham, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

UroMed was a medical technology company specializing in the development and commercialization of products for the urology market, with a particular focus on prostate cancer and urinary incontinence. The company was well-known for its involvement in prostate brachytherapy, providing the delivery systems and radioactive seeds used in the localized treatment of prostate tumors. Beyond oncology, UroMed developed innovative solutions for female urinary incontinence, such as the Reliance Urinary Control Insert. The company was eventually acquired by C. R. Bard, which integrated UroMed's urological portfolio into its own extensive medical device offerings.

Therapeutic areas: OncologyNephrologyMen's Health
Modalities: DeviceRadiopharmaceutical
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on UroMed Brachytherapy.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on UroMed Brachytherapy.

Explore the full profile